Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Bonder

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2024
Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitisEsli Medina-Morales, Mohamed Ismail, Ritik M Goyal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2025
Evolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinomaButros Fakhoury, Vinay Jahagirdar, Marwan Alsaqa, et al.
Journal of Clinical Medicine|March 27, 2025
Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing CholangitisTamara Kahan, Ana Marenco-Flores, Natalia Rojas Amaris, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 30, 2022
Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United StatesHaris Muhammad, Merve Gurakar, Peng-Sheng Ting, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|June 25, 2026
Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive ReviewVictoria E Abadi-Ron, Ana Marenco-Flores, Natalia Rojas-Amaris, et al.
Journal of Clinical Medicine|November 27, 2024
Acute Liver Failure Etiology Determines Long-Term Outcomes in Patients Undergoing Liver Transplantation: An Analysis of the UNOS DatabaseNatalia Rojas Amaris, Ana Marenco-Flores, Romelia Barba, et al.
World Journal of Transplantation|December 8, 2025
Association of vascular invasion and tumor differentiation on post-liver transplant outcomes in patients with hepatocellular carcinomaNazlı Begüm Öztürk, Merve M Gurakar, Ximena Parraga, et al.
Annals of Hepatology|November 22, 2021
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant - A retrospective cohort analysisKillian J McCarthy, Daniel Motta-Calderon, Alisson Estrada-Roman, et al.
Journal of Clinical Medicine|August 10, 2024
The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis PatientsAna Marenco-Flores, Natalia Rojas Amaris, Tamara Kahan, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinomaMarwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2024
Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitisEsli Medina-Morales, Mohamed Ismail, Ritik M Goyal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2025
Evolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinomaButros Fakhoury, Vinay Jahagirdar, Marwan Alsaqa, et al.
Journal of Clinical Medicine|March 27, 2025
Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing CholangitisTamara Kahan, Ana Marenco-Flores, Natalia Rojas Amaris, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 30, 2022
Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United StatesHaris Muhammad, Merve Gurakar, Peng-Sheng Ting, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|June 25, 2026
Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive ReviewVictoria E Abadi-Ron, Ana Marenco-Flores, Natalia Rojas-Amaris, et al.
Journal of Clinical Medicine|November 27, 2024
Acute Liver Failure Etiology Determines Long-Term Outcomes in Patients Undergoing Liver Transplantation: An Analysis of the UNOS DatabaseNatalia Rojas Amaris, Ana Marenco-Flores, Romelia Barba, et al.
World Journal of Transplantation|December 8, 2025
Association of vascular invasion and tumor differentiation on post-liver transplant outcomes in patients with hepatocellular carcinomaNazlı Begüm Öztürk, Merve M Gurakar, Ximena Parraga, et al.
Annals of Hepatology|November 22, 2021
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant - A retrospective cohort analysisKillian J McCarthy, Daniel Motta-Calderon, Alisson Estrada-Roman, et al.
Journal of Clinical Medicine|August 10, 2024
The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis PatientsAna Marenco-Flores, Natalia Rojas Amaris, Tamara Kahan, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinomaMarwan Alsaqa, Leandro Sierra, Ana Marenco-Flores, et al.
Pageof 10